Sanofi, Regeneron cancer drug Zaltrap gets EU nod

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

Singapore: European Commission has granted marketing authorization for Sanofi and Regeneron Pharmaceuticals (EC)'s Zaltrap 25mg/ml concentrate in the European Union. Zaltrap 25mg/ml solutio...Read more

Low R&D output, patent cliffs drives big pharma nuts

Drug Discovery |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

Singapore: According to the latest global report from industry experts, GBI Research, low R&D productivity, combined with the patent cliff and a stringent US FDA approval process, is re...Read more

Bayer, Compugen enter $500 mn cancer deal

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

Singapore: Israel-based Compugen and global pharmaceutical company Bayer are to jointly pursue a preclinical research program for research, development, and commercialization of antibody-ba...Read more

Taiho to start ph III trial in colorectal cancer

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

Singapore: Japan based-Taiho Pharmaceutical is starting global phase III clinical trial (RECOURSE) for the novel combination antimetabolite TAS-102 in June this year. RECOURSE is a randomi...Read more

FDA nod for Genentech pre-surgical cancer drug

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

Singapore: Genentech, a member of the Roche Group, has recieved US FDA approval for Perjeta (pertuzumab) regimen for neoadjuvant treatment (use before surgery) in people with high-risk, HER...Read more

FDA issues complete response letter for PREZISTA

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 31 May, 2012

Singapore: The US Food and Drug Administration (FDA) has issued a complete response letter to Janssen Therapeutics for Supplemental New Drug Application (sNDA) for an 800mg tablet of PREZI...Read more

Pharma majors join hands to find new cure for TB

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jun, 2012

Seven pharmaceutical companies and four research institutions, working with the Bill & Melinda Gates Foundation, recently launched a partnership that aims to speed the discovery of esse...Read more

GSK to publish clinical study reports of drugs

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 07 Feb, 2013

Singapore: Demonstrating its commitment to clinical trial transparency, multinational pharmaceutical company GlaxoSmithKline has announced its support for the AllTrials campaign. The campa...Read more

Ex-sanofi cancer head is PharmaEngine advisor

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 05 Mar, 2013

Singapore: Taiwan's PharmaEngine appointed Dr Alain Herrera as senior advisor for clinical strategy, operations, corporate strategy, licensing and alliance management. Dr Herrera previousl...Read more

Cold Spring Harbor Lab uses cancer drugs to treat Alzheimer's

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2012

Singapore: A team of American and Chinese neuroscientists at the Cold Spring Harbor Laboratory (CSHL) have carried out research to show that a class of currently used anti-cancer drugs as w...Read more

Chugai expands in Singapore with research institute

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2012

Singapore: Japan's Chugai Pharmabody Research (CPR) has started its operations in Singapore. The company started operations in Singapore on July 2, 2012. The opening ceremony was attended b...Read more

Australia invests in autoimmune disease start up firm

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Helmedix, an early stage biopharmaceutical company developing novel therapies for autoimmune and inflammatory diseases such as rheumatoid arthritis, colitis, psoriasis and multip...Read more

François-Xavier Roge is Takeda's new CFO

Drug Discovery |  Influencers | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2013

Singapore: Japan-headquartered global firm, Takeda Pharmaceutical, appointed Mr François-Xavier Roger as its chief financial officer (CFO), effective September 2, 2013.In his new role, M...Read more

Novartis, Regenerex further immune tolerance R&D

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Sep, 2013

Singapore: Novartis entered into an exclusive global licensing and research collaboration agreement with Regenerex, a biopharmaceutical company based in Louisville, Kentucky, US, for use of...Read more

Boehringer Ingelheim appoints board member

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

Singapore: The shareholders of Boehringer Ingelheim have appointed Dr Joachim Hasenmaier to Boehringer Ingelheim's board of managing directors. The 52-year-old will take over the responsibi...Read more

China develops revolutionary TCM migraine medication

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jul, 2012

Singapore: China Health Resource (CHRI) has developed a revolutionary TCM migraine medication called Toufeng Migraine tablet, which demonstrated an effective rate of 96.5 percent in clinica...Read more

Novartis eye care firm gets EU nod for Jetrea

Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

Singapore: Alcon, the global leader in eye care and a division of Novartis, has received European Commission's approval for Jetrea intravitreal injection (ocriplasmin) in the EU for the tre...Read more

QRxPharma to resubmit NDA to FDA for pain relieving drug

Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: Australia's QRxPharma has received Complete Response Letter (CRL) from USFDA for its MOXDUO New Drug Application (NDA) for treatment of moderate to severe acute pain.With the iss...Read more